Access cutting-edge cardiac amyloidosis treatment through this clinical trial at a research site in Duarte. Study-provided care at no cost to qualified participants.
Access cardiac amyloidosis specialists in Duarte at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cardiac amyloidosis treatment provided free
The purpose of this Phase 3, open label, single dose imaging study is to evaluate the efficacy and safety of I-124 evuzamitide (radioactive dye) for diagnosing Cardiac Amyloidosis in participants with suspected Cardiac Amyloidosis. The imaging test that will be used in this study is a Positron Emission Tomography Computed Tomography (PET/CT) scan.
Sponsor: Sharmila Dorbala
Check if you qualify for this cardiac amyloidosis clinical trial in Duarte, CA
If you're searching for cardiac amyloidosis treatment options in Duarte, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Duarte research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cardiac amyloidosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.